IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 616 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (1,458 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures
   Article Tables

 Article Access Statistics
    Viewed2478    
    Printed52    
    Emailed0    
    PDF Downloaded67    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR - CASE LETTER
Year : 2016  |  Volume : 82  |  Issue : 6  |  Page : 702-704

H syndrome with histological features of Langerhans cell histiocytosis


1 Department of Dermatology, Anatomy and Cytology, Farhat Hached Hospital, Sousse, Tunisia
2 Department of Medical Genetics, Anatomy and Cytology, Farhat Hached Hospital, Sousse, Tunisia
3 Department of Biochemistry and Molecular Biology, Trousseau Hospital, Paris, France
4 Department of Pathological Anatomy and Cytology, Anatomy and Cytology, Farhat Hached Hospital, Sousse, Tunisia

Date of Web Publication7-Oct-2016

Correspondence Address:
Dr. Mouna Korbi
Department of Dermatology, Farhat Hached Hospital, Sousse
Tunisia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.185044

Rights and Permissions



How to cite this article:
Korbi M, Aounallah A, Hmida D, Ghariani N, Saidi W, Boussofara L, Belajouza C, Jonard L, Sriha B, Saad A, Denguezli M, Nouira R. H syndrome with histological features of Langerhans cell histiocytosis. Indian J Dermatol Venereol Leprol 2016;82:702-4

How to cite this URL:
Korbi M, Aounallah A, Hmida D, Ghariani N, Saidi W, Boussofara L, Belajouza C, Jonard L, Sriha B, Saad A, Denguezli M, Nouira R. H syndrome with histological features of Langerhans cell histiocytosis. Indian J Dermatol Venereol Leprol [serial online] 2016 [cited 2019 Oct 21];82:702-4. Available from: http://www.ijdvl.com/text.asp?2016/82/6/702/185044


Sir,

The H syndrome (OMIM 602782) is a very rare autosomal recessive disorder first described by Molho-Pessach in 2008 and refers to a constellation of clinical and laboratory findings.[1],[2],[3],[4] This disorder has been recently shown to be caused by mutations in the SLC29A3 gene encoding the human equilibrative nucleoside transporter.[5] We report a novel case of H syndrome with a particular histological and genetic presentation.

The patient followed up with us since the age of 14 years for progressive sclerodermatous thickening of the skin, with overlying hyperpigmentation and hypertrichosis on the limbs [Figure 1]. In addition, he was followed up in the endocrinology department since the age of 16 years for insulin-dependent diabetes mellitus, short stature and dysmorphic features. The child also had sensorineural hearing loss from the age of 9 years. He was born after a normal pregnancy to non-related parents of Tunisian origin. His brother and two sisters were healthy. On physical examination, we noted bilateral gynecomastia [Figure 1], short stature, hepatosplenomegaly, flexion contractures of the fingers and toes, hallux valgus and a micropenis. Indurated and hyperpigmented patches were present on the middle and lower half of the body, extending over the trunk and neck. He was not found to have cardiovascular or ocular anomalies. Laboratory investigations revealed low rates of insulin growth factor type 1, insulin growth factor binding protein type 3 and testosterone. A growth hormone stimulation test with arginine did not indicate growth hormone deficiency. Thyroid function tests and karyotype were normal.
Figure 1: Extensive hyperpigmentation over upper limbs and thighs, and prominent gynecomastia

Click here to view


Histopathological examination of involved skin showed hyperpigmentation of the basal layer with infiltration by histiocytes [Figure 2]. Immunohistochemistry showed positivity with both CD1a and PS100 [Figure 3]. However, CD68 was negative. A perivascular mononuclear infiltrate with plasma cells and mast cells throughout the dermis and subcutaneous fat was noted. Blood samples were collected from the patient and his parents. Informed consent was obtained from each of them. Mutation analysis of genomic DNA confirmed the diagnosis of H syndrome in our patient and showed that he was a compound heterozygote for two types of mutations in exon 6 of the SLC29A3 gene (described below).
Figure 2: Marked fi brosis of the dermis and superfi cial subcutis with chronic perivascular infl ammatory infi ltrates (H and E, ×400)

Click here to view
Figure 3: (a) The lymphoid cells are seen to be mostly T cells (CD3+) (b) with histiocytes which are CD1a+ (c) histiocytes are also positive with PS100

Click here to view


More than a hundred cases of the H syndrome have been reported.[2] Major systemic features include hearing loss, heart anomalies, hepatosplenomegaly, hypogonadism and hyperglycemia. A hallmark of this syndrome is the cutaneous hyperpigmentation which is accompanied by sclerodermatous thickening and hypertrichosis.[3] The lower limbs are the most common site described with cutaneous hyperpigmentation. Flexion contractures of the fingers and toes are the second most common feature.[3] In a recent study which focuses on the spectrum of radiological findings in the H syndrome, severe symmetrical deformation was demonstrated.[6] Sensorineural hearing loss is the third most common clinical finding. A recent report describes two cases of H syndrome who had hearing loss as a prominent feature.[7] Lymphadenopathy has been described as another feature.[3] According to a recent review, insulin-dependent diabetes mellitus was observed in 18 (23%) patients, and this may be the sole presentation.[8] Micropenis has also been observed.[3],[4] Further, several other biological anomalies such as hypertriglyceridemia, anemia, red cell aplasia/dyserythropoiesis and pancytopenia have been described in the literature.[3],[4],[9] Hormonal evaluation was done in some studies. A growth hormone stimulation test with arginine was consistent with growth hormone deficiency, providing an explanation for the short stature.[1],[4] Low insulin-like growth factor 1 level was reported as another contributing factor to short stature. The sex hormone profile showed relatively high gonadotropins and low testosterone levels, indicating primary hypogonadism.[1],[4] Our patient had many of these findings [Table 1].
Table 1: The clinical and biological fi ndings characterizing H syndrome in our patient compared with those reported in the literature

Click here to view


Skin biopsy specimens in the H syndrome demonstrate polyclonal perivascular lympho-histiocytic infiltrates and hyperpigmentation of the basal layer,[5] as with our patient. However, in our case, immunohistochemical stains showed histiocytes positive for CD1a and PS100, a feature not described earlier. Our patient could therefore be considered as having a variant of H syndrome, within the spectrum of inherited histiocytosis.

Till now, only twenty mutations have been identified in the H syndrome.[3] Our patient had two different mutations previously described: a missense mutation c. 1088G>A changing arginine 363 to glutamine (p. Arg363Gln) previously detected in Arab patients and a splice site mutation, c. 300+1G>A which was reported in Pakistani patients.[5] The spectrum of phenotypes related to SLC29A3 mutations appears to be very wide, ranging from a severe syndrome as in our patient, to a very mild clinical presentation. No clear correlation between any of the clinical features and a specific mutation has been found. In fact, patients with a mild phenotype have been identified after mutation screening in families with severely affected individuals.[4] There is no specific treatment for this syndrome, and genetic counseling is essential.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
Molho-Pessach V, Agha Z, Aamar S, Glaser B, Doviner V, Hiller N, et al. The H syndrome: A genodermatosis characterized by indurated, hyperpigmented, and hypertrichotic skin with systemic manifestations. J Am Acad Dermatol 2008;59:79-85.  Back to cited text no. 1
[PUBMED]    
2.
Sharad M, Vaishali M, Asit M, Achok KK, Lalit GK. The H syndrome. Indian J Peadiatric Dermatol 2015;16:102-4.  Back to cited text no. 2
    
3.
Molho-Pessach V, Ramot Y, Camille F, Doviner V, Babay S, Luis SJ, et al. Hsyndrome: The first 79 patients. J Am Acad Dermatol 2014;70:80-8.  Back to cited text no. 3
[PUBMED]    
4.
Molho-Pessach V, Lerer I, Abeliovich D, Agha Z, Abu Libdeh A, Broshtilova V, et al. The H syndrome is caused by mutations in the nucleoside transporter hENT3. Am J Hum Genet 2008;83:529-34.  Back to cited text no. 4
[PUBMED]    
5.
Jonard L, Couloigner V, Pierrot S, Louha M, Gherbi S, Denoyelle F, et al. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: A very mild phenotype. Eur J Med Genet 2012;55:56-8.  Back to cited text no. 5
[PUBMED]    
6.
Hiller N, Zlotogorski A, Simanovsky N, Ingber A, Ramot Y, Molho-Pessach V. The spectrum of radiological findings in H syndrome. Clin Imaging 2013;37:313-9.  Back to cited text no. 6
[PUBMED]    
7.
Ramot Y, Sayama K, Sheffer R, Doviner V, Hiller N, Kaufmann-Yehezkely M, et al. Early-onset sensorineural hearing loss is a prominent feature of H syndrome. Int J Pediatr Otorhinolaryngol 2010;74:825-7.  Back to cited text no. 7
[PUBMED]    
8.
Broshtilova V, Ramot Y, Molho-Pessach V, Zlotogorski A. Diabetes mellitus may be the earliest and sole manifestation of the H syndrome. Diabet Med 2009;26:1179-80.  Back to cited text no. 8
[PUBMED]    
9.
Priya TP, Philip N, Molho-Pessach V, Busa T, Dalal A, Zlotogorski A. H syndrome: Novel and recurrent mutations in SLC29A3. Br J Dermatol 2010;162:1132-4.  Back to cited text no. 9
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow